Document is current
Any future updates will be listed below
-
Authors
Maya-Vetencourt, José Fernando
Manfredi, Giovanni
Mete, Maurizio
Colombo, Elisabetta
Bramini, Mattia https://orcid.org/0000-0002-0381-9391
Di Marco, Stefano
Shmal, Dmytro https://orcid.org/0000-0001-6770-6364
Mantero, Giulia https://orcid.org/0000-0003-3381-1400
Dipalo, Michele https://orcid.org/0000-0002-1823-8231
Rocchi, Anna
DiFrancesco, Mattia L. https://orcid.org/0000-0002-7511-4438
Papaleo, Ermanno D.
Russo, Angela
Barsotti, Jonathan
Eleftheriou, Cyril
Di Maria, Francesca
Cossu, Vanessa https://orcid.org/0000-0002-7302-7429
Piazza, Fabio https://orcid.org/0000-0001-8021-9288
Emionite, Laura
Ticconi, Flavia
Marini, Cecilia
Sambuceti, Gianmario
Pertile, Grazia
Lanzani, Guglielmo https://orcid.org/0000-0002-2442-4495
Benfenati, Fabio https://orcid.org/0000-0002-0653-8368
- License Information
-
More Information
Article History
Received: 21 January 2019
Accepted: 20 April 2020
First Online: 29 June 2020
Competing interests
: The P3HT NPs studied in this paper are the subject of the US patent application US 16/005248 ‘Eye-injectable polymeric nanoparticles and method of use therefor’ by Istituto Italiano di Tecnologia and Ospedale Sacrocuore Don Calabria, with J.F.M.-V., M.M., G.P., F.B. and G.L. as inventors. The other authors declare no competing interests.
